Evidence map›Paper›PMID 36471283›Full record

ArticleBMC infectious diseases2022

Five consecutive epidemiological waves of COVID-19: a population-based cross-sectional study on characteristics, policies, and health outcome.

Rozhin Amin, Mohammad-Reza Sohrabi, Ali-Reza Zali, Khatereh Hannani

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Review
  3. Community pharmacy resiliency during Covid-19 pandemic in Iran: A qualitative study.Exploratory research in clinical and social pharmacy · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Outcome Comparison in Hospitalized COVID-19 Patients With and Without AKI.Journal of community hospital internal medicine perspectives · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Rozhin AminCommunity Medicine Department, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, 19839-63113, Iran.
Mohammad-Reza SohrabiCommunity Medicine Department, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, 19839-63113, Iran. m.sohrabi@sbmu.ac.ir.
Ali-Reza ZaliFunctional Neurosurgery Research Centre, Shahid Beheshti University of Medical Sciences, Tehran, 19839-63113, Iran.
Khatereh HannaniStatistics and Information Technology Management, Shahid Beheshti University of Medical Sciences, Tehran, 19839-63113, Iran.
Shahid Beheshti University of Medical Sciences · IR

Funding

Research Deputy of the School of Medicine at Shahid Beheshti University of Medical Sciences in Tehran, Iran 28911
6 · The paper itself

Abstract

backgroundThis study was conducted with the intension of providing a more detailed view about the dynamics of COVID-19 pandemic. To this aim, characteristics, implemented public health measures, and health outcome of COVID-19 patients during five consecutive waves of the disease were assessed.

methodsThis study was a population-based cross-sectional analysis of data on adult patients who were diagnosed with COVID-19 during five waves of the disease in Iran. Chi-squared test, One-way ANOVA, and Logistic Regression analysis were applied. A detailed literature review on implemented public health policies was performed by studying published documents and official websites responsible for conveying information about COVID-19.

resultsData on 328,410 adult patients was analyzed. Main findings indicated that the probability of dying with COVID-19 has increased as the pandemic wore on, showing its highest odd during the third wave (odds ratio: 1.34, CI: 1.283-1.395) and has gradually decreased during the next two waves. The same pattern was observed in the proportion of patients requiring ICU admission (P < 0.001). First wave presented mainly with respiratory symptoms, gastrointestinal complaints were added during the second wave, neurological manifestations with peripheral involvement replaced the gastrointestinal complaints during the third wave, and central nervous system manifestations were added during the fourth and fifth waves. A significant difference in mean age of patients was revealed between the five waves (P < 0.001). Moreover, results showed a significant difference between men and women infected with COVID-19, with men having higher rates of the disease at the beginning. However, as the pandemic progressed the proportion of women gradually increased, and ultimately more women were diagnosed with COVID-19 during the fifth wave. Our observations pointed to the probability that complete lockdowns were the key measures that helped to mitigate the virus spread during the first twenty months of the pandemic in the country.

conclusionA changing pattern in demographic characteristics, clinical manifestations, and severity of the disease has been revealed as the pandemic unfolded. Reviewing COVID-19-related public health interventions highlighted the importance of immunization and early implementation of restrictive measures as effective strategies for reducing the acute burden of the disease.

Indexed as

COVID-19AdultCommunicable Disease ControlCross-Sectional StudiesFemaleHumansMaleOutcome Assessment, Health CarePandemicsPolicyCOVID-19EpidemicsEpidemiologyIranPandemicsPopulation characteristics

Identifiers

PMID36471283
PMCPMC9721063
OpenAlexW4311283835

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.